Tgtr.Ta
TGTR.TA operates in the Healthcare sector, specifically in Healthcare Services & Equipment, and is classified under the Pharmaceuticals activity. The company generates revenue primarily through the provision of healthcare services and equipment.
Business. TGTR.TA operates in the Healthcare sector, specifically in Healthcare Services & Equipment, and is classified under the Pharmaceuticals activity. The company generates revenue primarily through the provision of healthcare services and equipment.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
TGTR.TA operates in the Healthcare sector, specifically in Healthcare Services & Equipment, and is classified under the Pharmaceuticals activity. The company generates revenue primarily through the provision of healthcare services and equipment.
TGTR.TA has a debt-to-equity ratio of 1.24, indicating a moderate level of leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.32, suggesting it can cover its short-term liabilities but with limited buffer. The company's free cash flow of 8,051,000 ILS indicates positive cash generation from operations after capital expenditures.
In terms of profitability, TGTR.TA reports a return on equity (ROE) of 3.98% and a return on assets (ROA) of 1.24%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks if the primary segment or region experiences a downturn.
Looking ahead, TGTR.TA is projected to see a modest growth in revenue, with the current fiscal year outlook showing a slight increase from the previous year. The company's capital expenditure of -1,414,000 ILS suggests a reduction in investment in physical assets, which may indicate a strategic shift or a focus on cost optimization. The risk assessment indicates a low potential for dilution, with no significant dilution events reported in the recent financial data.
Recent filings and transcripts do not highlight any major events or strategic shifts for TGTR.TA. The company's financial statements and disclosures remain consistent with its historical operations, with no significant changes in business strategy or market position.
- TGTR.TA has a moderate level of leverage with a debt-to-equity ratio of 1.24.
- The company's ROE and ROA are below the industry median, indicating underperformance in capital efficiency and asset utilization.
- Revenue is concentrated in a single segment, increasing exposure to market and operational risks.
- The company is projected to see modest revenue growth in the current fiscal year.
- TGTR.TA has a low potential for dilution, with no significant dilution events reported.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- TGTR.TA Market data — financials · 2026-05-29